User profiles for Chad C. Wiggins

Chad Wiggins

Michigan State University
Verified email at msu.edu
Cited by 3426

Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients

…, KL Kunze, PW Johnson, ER Lesser, CC Wiggins… - Mayo Clinic …, 2020 - Elsevier
Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …

[HTML][HTML] Early safety indicators of COVID-19 convalescent plasma in 5000 patients

…, RE Carter, AM Klompas, CC Wiggins… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Convalescent plasma is the only antibody-based therapy currently available
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …

[HTML][HTML] Convalescent plasma antibody levels and the risk of death from Covid-19

…, PW Johnson, ES Theel, CC Wiggins… - … England Journal of …, 2021 - Mass Medical Soc
Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19)
under the presumption that such plasma contains potentially therapeutic …

Effect of convalescent plasma on mortality among hospitalized patients with COVID-19: initial three-month experience

…, JR Mills, PW Johnson, ES Theel, CC Wiggins… - medrxiv, 2020 - medrxiv.org
Importance Passive antibody transfer is a longstanding treatment strategy for infectious
diseases that involve the respiratory system. In this context, human convalescent plasma has …

[HTML][HTML] Ergogenic effect of nitrate supplementation: A systematic review and meta-analysis

JW Senefeld, CC Wiggins, RJ Regimbal… - Medicine and science …, 2020 - ncbi.nlm.nih.gov
Although over 100 studies and reviews have examined the ergogenic effects of dietary nitrate
(NO 3−) supplementation in young, healthy men and women, it is unclear if participant and …

[HTML][HTML] The effect of convalescent plasma therapy on mortality among patients with COVID-19: systematic review and meta-analysis

…, PW Johnson, RE Carter, CC Wiggins… - Mayo Clinic …, 2021 - Elsevier
To determine the effect of COVID-19 convalescent plasma on mortality, we aggregated
patient outcome data from 10 randomized clinical trials, 20 matched control studies, 2 dose-…

Use of convalescent plasma in COVID‐19 patients with immunosuppression

…, SA Klassen, SK Ford, KA Senese, CC Wiggins… - …, 2021 - Wiley Online Library
In the absence of effective countermeasures, human convalescent plasma has been widely
used to treat severe acute respiratory syndrome coronavirus 2, the causative agent of novel …

[HTML][HTML] Convalescent plasma therapy for COVID-19: a graphical mosaic of the worldwide evidence

…, KA Senese, PW Johnson, CC Wiggins… - Frontiers in …, 2021 - frontiersin.org
Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus
disease 2019 (COVID-19) and prevent disease progression. Despite global usage, …

[HTML][HTML] Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study

…, BJ Grossman, AAR Tobian, R Goel, CC Wiggins… - PLoS …, 2021 - journals.plos.org
Background The United States (US) Expanded Access Program (EAP) to coronavirus disease
2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of …

[PDF][PDF] Ischemic preconditioning, O2 kinetics, and performance in normoxia and hypoxia

CC Wiggins, K Constantini, HL Paris… - Medicine & Science …, 2019 - researchgate.net
Ischemic preconditioning (IPC) before exercise has been shown to be a novel approach to
improve performance in different exercise modes in normoxia (NORM). Few studies have …